Article
Comparison of small biopsy specimens and surgical specimens for the detection of EGFR mutations and EML4-ALK in non-small-cell lung cancer.
Oncotarget - 13 Sept 2016
Xiao DeSheng, Lu Can, Zhu Wei, He QiuYan, Li Yong, Fu ChunYan, Zhou JianHua, Liu Shuang, Tao YongGuang
Abstract excerpt
Epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) fusion genes represent novel oncogenes that are associated with non-small-cell lung cancers (NSCLC). The feasibility of detecting EGFR mutations and ALK fusion genes in small biopsy specimens or surgical specimens was determined. Of the 721 NSCLC patients, a total of 305 cases were positive for EGFR mutations (42.3%). The rate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
